1Wilson SH,Best PJ,Edwards WD,et al.Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris.Atherosclerosis,2002,160:147-153.
2Fan H,Sun B,Gu Q,et al.Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart.Am J Physiol Heart Circ Physiol,2002,282:1778-1786.
3May MJ,Ghosh S.Signal transduction through NF-κB.Immunol Today,l998,19:80-88.
4Pueyo ME,Gonzalez W,Nicoletti A,et al.Angiotensin II stimulates endothelial vascular cell adhesion molecular-1 via nuclear factor-kB activation induced by intracellular oxidative stress.Arterio Thromb Vasc Biol,2000,20:645-651.
5Warnholtz A,Nickenig G,Schulz E,et al.Increased NADH-oxidase mediated superoxide production in the early stages of atherosclerosis.evidence of involvement of the renin angiotensin system.Circulation,1999,99:2027-2033.
6Brasier AR,Recinos A,Eledrisi MS.Vascular inflammation and the renin-angiotensin system.Arterioscler Thromb Vasc Biol,2002,22:1257-1266.
7Kazmierski R,Kozubski W.Effect of Chlamydia pneumoniae infection on carotid atherosclerosis development.Neurol Neurochir Pol,2002,36:131-142.
8Barnes PJ,Karin M.Nuclear factor-κBα pivotal transcription factor in chronic inflammatory diseases.New Eng J Med,1997,336:1066-1071.
9Li D,Chen H,Romeo F,et al.Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1.J Pharmacol Exp Ther,2002,302:601-605.
10Ortego M,Bustos C,Hernandez-presa MA,et al.Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.Atherosclerosis,1999,147:253-261.
同被引文献21
1Sandberg WJ,Yndestad A, Oie E, et al. Enhanced T cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol, 2006, 26: 857-863.
2Gareus R, Kotsaki E, Xanthoulea S, et al. Endothelial cell-specific NF-kappa B inhibition protects mice from atherosclerosis. Cell Metab, 2008, 8:372-383.
3Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. AmJ Cardiol, 1983, 51: 606.
4Biasucci LM, Leo M, De Maria GL. Local and systemic mechanisms of plaque rupture. Angiology, 2008,59:73S-76S.
5Ross R. Atheroselerosis: an inflammatory disease. N Engl J Med, 1999, 340: 115-126.
6Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol,2003,41:15S-22S.
7de Winther MP,Kanters E, Kraal G, et al. Nuclear factor kappa B signaling in atherogenesis. Arterioscler Thromb Vasc Biol, 2005,25: 904-914.
8Monaco C, Andreakos E, Kiriakidis S, et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci,2004,101:5634 -5639.
9Waltenberger J. Pathophysiological bases of unstable coronary syndrome. Herz, 2001,26:2-8.
